This mutation was not previously described as germline alteration, but is likely to be functionally relevant, because it is a somatic hot-spot mutation recurrently found in ‘ultramutated’ sporadic colorectal and endometrial cancers with a mutational profile characteristic for impaired Pol ε exonuclease activity [12]. This evidence concerns the gene EPX and endometrial cancer.